FIELD: medicine.
SUBSTANCE: present invention concerns pharmacology and represents a pharmaceutical composition containing therapeutically effective protein and nondetergent sulfobetaine (NDSB) where NDSB is chosen from the group containing dimethylethyl-(3-sulfopropil)ammonium salt, 3-(1-pyridino)-1-propanesulfonate, propanesulfonate dimethylbenzylammonium, dimethyl-tert-butyl-(3-sulfopropyl)ammounium salt, 3-(1-methylpiperidine)-1-propanesulfonate and dimethyl-(2-hydroxyethyl)- (sulfopropyl)ammounium salt.
EFFECT: invention provides preparation of the stabilised pharmaceutical compositions.
8 cl, 2 ex, 3 tbl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID COMPOSITION G-CSF | 2007 |
|
RU2445115C2 |
| LIQUID FORMULATIONS FOR LONG-ACTING CONJUGATE OF G-CSF | 2011 |
|
RU2519031C1 |
| LYOPHILIZED IMMUNOCYTOKINE-CONTAINING PREPARATION | 2003 |
|
RU2316348C2 |
| FLUID FORMULATION OF FOLLICLE-STIMULATING HORMONE | 2011 |
|
RU2553375C2 |
| WATER-SOLUBLE PHARMACEUTICAL COMPOSITION AS IONIC COMPLEX AND ITS USE | 1999 |
|
RU2180855C2 |
| DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2005 |
|
RU2390355C2 |
| STABLE NON-AQUEOUS PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2472492C2 |
| STABLE LIQUID COMPOSITION OF FUSED PROTEIN WITH DOMAIN Fc IgG | 2016 |
|
RU2688679C1 |
| STABLE LIQUID ETANERCEPT COMPOSITION | 2012 |
|
RU2575619C2 |
| IMPROVED METHOD OF PEGYLATING PROTEINS | 2009 |
|
RU2472806C1 |
